AOCNP Professional Role, Ethics, and Legal Issues in Advanced Practice Oncology Nursing — Questions and Answers
Question 1: A patient with metastatic lung cancer has previously completed a POLST (Physician Orders for Life-Sustaining Treatment) form indicating DNR/DNI status. During a hospitalization, the patient's adult daughter insists the team 'do everything possible.' What is the oncology NP's most appropriate action?
- Defer to the family's wishes since the daughter is next of kin
- Honor the patient's documented POLST, which reflects the patient's own autonomous choices (Correct answer)
- Suspend the POLST and initiate a family meeting before providing any care
- Consult the ethics committee before providing any care to the patient
Correct answer: Honor the patient's documented POLST, which reflects the patient's own autonomous choices
A POLST is a legally recognized medical order reflecting the patient's autonomous wishes regarding life-sustaining treatment. It supersedes family preferences when the patient lacks current decision-making capacity and previously had capacity when completing the form. The patient's documented autonomous choice must be respected. Family members do not override a valid POLST. Ethics consultation can be considered for ongoing family conflict but is not required before honoring the existing legal order.
Question 2: When obtaining informed consent for a Phase I oncology clinical trial, which element distinguishes informed consent in this context from standard treatment consent?
- Patients must be informed that the primary purpose is to determine safety and dose, not to achieve tumor response (Correct answer)
- Consent can be waived if the patient has limited treatment options
- A legally authorized representative may consent on behalf of a competent adult patient
- Patients in Phase I trials are not permitted to withdraw consent after enrollment
Correct answer: Patients must be informed that the primary purpose is to determine safety and dose, not to achieve tumor response
A critical and ethically mandated element of Phase I trial consent is explicitly informing participants that the primary objective is to evaluate safety, pharmacokinetics, and determine the maximum tolerated dose — not to provide therapeutic benefit. This distinction addresses therapeutic misconception, where participants mistakenly believe the trial is primarily designed to help them. Consent cannot be waived for competent adults. A competent adult must consent personally. Withdrawal of consent is always permitted.
Question 3: An oncology NP suspects a colleague is documenting chemotherapy administration that was not actually performed. Which action represents the NP's primary professional and legal obligation?
- Confront the colleague privately and give them the opportunity to self-report
- Report the concern through the institution's established reporting chain or compliance office (Correct answer)
- Document personal observations carefully and wait for more evidence before acting
- Contact the patient's family to alert them to potential care discrepancies
Correct answer: Report the concern through the institution's established reporting chain or compliance office
Documenting care that was not performed constitutes healthcare fraud and potentially endangers patient safety. The NP's professional and legal obligation — as articulated in ANA and ONCC standards — is to report the concern through established institutional channels (charge nurse, manager, compliance hotline, or risk management) without delay. Confronting the colleague privately may allow continued misconduct. Waiting for more evidence delays patient protection. Contacting the family directly bypasses proper institutional process.
Question 4: Which ethical principle is most prominently invoked when an oncology NP advocates for a patient's right to refuse further chemotherapy despite family pressure to continue treatment?
- Beneficence
- Non-maleficence
- Autonomy (Correct answer)
- Justice
Correct answer: Autonomy
Autonomy — the right of a competent individual to make decisions about their own body and care without coercion — is the core principle at stake when honoring a patient's informed refusal of treatment. Beneficence refers to acting in the patient's best interest. Non-maleficence means avoiding harm. Justice involves fair distribution of resources. Advocacy for a patient's treatment refusal against external pressure is a classic application of respecting autonomy.
Question 5: Under the Oncology Nursing Society's (ONS) standards, which activity falls within the established scope of practice for an AOCNP in most states?
- Independently performing surgical resection of a tumor without physician oversight
- Prescribing chemotherapy regimens within a collaborative practice model (Correct answer)
- Interpreting and reporting pathology slides independently
- Performing bone marrow transplant procedures without oversight
Correct answer: Prescribing chemotherapy regimens within a collaborative practice model
AOCNPs practice within advanced practice registered nurse (APRN) scope, which in most states includes independent or collaborative prescribing of medications, including chemotherapy, within an established oncology practice framework and collaborative agreements where required. Surgical procedures, pathology interpretation, and transplant procedures fall within physician (surgeon, pathologist, transplant physician) scope of practice and are not within NP scope regardless of certification.
Question 6: A hospital implements a new protocol for managing chemotherapy-induced nausea and vomiting (CINV). The oncology NP leads the quality improvement (QI) project. Which framework is most appropriate for structuring iterative improvement cycles in this project?
- SWOT analysis
- PDSA (Plan-Do-Study-Act) cycle (Correct answer)
- Root cause analysis (RCA)
- Failure mode and effects analysis (FMEA)
Correct answer: PDSA (Plan-Do-Study-Act) cycle
The PDSA (Plan-Do-Study-Act) cycle is the standard QI methodology for testing and implementing iterative improvements in clinical practice, endorsed by IHI and commonly used in oncology QI initiatives. SWOT analysis assesses organizational strengths/weaknesses but doesn't drive improvement cycles. RCA is a retrospective tool for analyzing adverse events. FMEA is a prospective risk assessment tool used in process safety, not iterative protocol improvement.
A patient with metastatic lung cancer has previously completed a POLST (Physician Orders for Life-Sustaining Treatment) form indicating DNR/DNI status.
During a hospitalization, the patient's adult daughter insists the team 'do everything possible.' What is the oncology NP's most appropriate action?